Publication:
Papillophlebitis Associated With the Use of Oral Contraceptive: A Case Report

dc.authorscopusid54401920900
dc.authorscopusid8540670700
dc.authorscopusid25723204700
dc.authorscopusid56689513900
dc.authorscopusid6603543240
dc.contributor.authorYücel, O.E.
dc.contributor.authorGüngör, I.
dc.contributor.authorGül, A.
dc.contributor.authorTurgut, M.
dc.contributor.authorAritürk, N.
dc.date.accessioned2020-06-21T13:51:11Z
dc.date.available2020-06-21T13:51:11Z
dc.date.issued2015
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Yücel] Özlem Eşki, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Güngör] Inci Ulu, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Gül] Adem, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Turgut] Mehmet, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Aritürk] Nurşen, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractWe present a 20-year-old female patient with papillophlebitis in the right eye. Minimal expansion of the blind spot and nasal peripheral defects in the right eye visual field were detected. The patient was using ethinyl estradiol-cyproterone acetate for ovarian cyst and menstrual irregularity. An improvement in the patient's visual field began within a week after cessation of ethinyl estradiol-cyproterone acetate. Ophthalmoscopic findings resolved completely in the sixth week. This situation suggests that female sex hormones or thromboembolic process caused by them may be responsible for the pathogenesis of papillophlebitis. But the exact mechanism in the pathogenesis of papillophlebitis is still controversial. © 2015 © 2015 Taylor & Francis.en_US
dc.identifier.doi10.3109/09513590.2015.1056139
dc.identifier.endpage603en_US
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.issue8en_US
dc.identifier.pmid26291803
dc.identifier.scopus2-s2.0-84942823804
dc.identifier.scopusqualityQ3
dc.identifier.startpage601en_US
dc.identifier.urihttps://doi.org/10.3109/09513590.2015.1056139
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14617
dc.identifier.volume31en_US
dc.identifier.wosWOS:000369941900006
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherTaylor and Francis Ltd healthcare.enquiries@informa.comen_US
dc.relation.ispartofGynecological Endocrinologyen_US
dc.relation.journalGynecological Endocrinologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBig Blind Spot Syndromeen_US
dc.subjectEthinyl Estradiol-Cyproterone Acetateen_US
dc.subjectFemale Sex Hormoneen_US
dc.subjectPapillophlebitisen_US
dc.titlePapillophlebitis Associated With the Use of Oral Contraceptive: A Case Reporten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files